| Literature DB >> 27008092 |
Céline Bouillon1, Roger Léandri2, Laurent Desch3, Alexandra Ernst4, Céline Bruno3, Charline Cerf4, Alexandra Chiron5, Céline Souchay4, Antoine Burguet6, Clément Jimenez7, Paul Sagot8, Patricia Fauque3.
Abstract
In animal studies, extensive data revealed the influence of culture medium on embryonic development, foetal growth and the behaviour of offspring. However, this impact has never been investigated in humans. For the first time, we investigated in depth the effects of embryo culture media on health, growth and development of infants conceived by In Vitro Fertilization until the age of 5 years old. This single-centre cohort study was based on an earlier randomized study. During six months, in vitro fertilization attempts (No. 371) were randomized according to two media (Single Step Medium--SSM group) or Global medium (Global group). This randomized study was stopped prematurely as significantly lower pregnancy and implantation rates were observed in the SSM group. Singletons (No. 73) conceived in the randomized study were included (42 for Global and 31 for SSM). The medical data for gestational, neonatal and early childhood periods were extracted from medical records and parental interviews (256 variables recorded). The developmental profiles of the children in eight domains (social, self-help, gross motor, fine motor, expressive language, language comprehension, letter knowledge and number knowledge--270 items) were compared in relation to the culture medium. The delivery rate was significantly lower in the SSM group than in the Global group (p<0.05). The culture medium had no significant effect on birthweight, risk of malformation (minor and major), growth and the frequency of medical concerns. However, the children of the Global group were less likely than those of the SSM group to show developmental problems (p = 0.002), irrespective of the different domains. In conclusion, our findings showed that the embryo culture medium may have an impact on further development.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27008092 PMCID: PMC4805279 DOI: 10.1371/journal.pone.0150857
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Components of both culture media according to published analyses*.
| Component Type | ||||
|---|---|---|---|---|
| Sodium Chloride | + | + | ||
| Potassium Chloride | + | + | ||
| Magnesium Sulfate | + | + | ||
| Calcium Chloride | + | + | ||
| Potassium Phosphate | + | + | ||
| Sodium Bicarbonate | + | + | ||
| Glucose | + | + | ||
| Sodium Pyruvate | + | + | ||
| Sodium Lactate | + | + | ||
| Arginine | + | + | ||
| Cysteine | + | + | ||
| Histidine | + | + | ||
| Isoleucine | + | + | ||
| Leucine | + | + | ||
| Lysine | + | + | ||
| Methionine | + | + | ||
| Phenylalanine | + | + | ||
| Threonine | + | + | ||
| Tryptophan | + | + | ||
| Tyrosine | + | + | ||
| Valine | + | + | ||
| Alanine | + | + | ||
| Asparagine | + | + | ||
| Aspartic acid | + | + | ||
| Glutamic acid | + | + | ||
| Glycine | + | + | ||
| Proline | + | + | ||
| Serine | + | + | ||
| Taurine | - | + | ||
| Glycyl-L-Glutamine | Alanyl-L-Glutamine | |||
| EDTA | + | + | ||
| Phenol Red | + | + | ||
| Gentamicin | + | + | ||
* Zhao et al., 2013; Morbeck et al., 2014
Pregnancy outcomes.
| Global group | SSM group | Rate Ratio | p | |
|---|---|---|---|---|
| Implantation (% per embryo transferred | 82 (29.1%) | 48 (16.3%) | 1.78 [1.31–2.43] | 0.001 |
| Clinical pregnancies (% per cycle | 66 (36.9%) | 42 (21.9%) | 1.68 [1.22–2.33] | 0.001 |
| Twin pregnancies (% per clinical pregnancy) | 8 (12.1%) | 4 (9.5%) | 1.27 [0.41–3.96] | 0.76 |
| Early spontaneous abortion (% by positive pregnancy test) | 18 (24.7%) | 9 (18.0%) | 1.37 [0.68–2.78] | 0.38 |
| Ectopic pregnancy (% by positive pregnancy test) | 1 (1.4%) | 0 (0%) | NC | - |
| Therapeutic abortions (% by positive pregnancy test) | 1 | 0 (0%) | NC | - |
| Delivery of live-born children (% per cycle | 50 (27.9%) | 35 (18.2%) | 1.53 [1.05–2.23] | 0.03 |
| Delivery of singleton (% per total number of live birth deliveries) | 42 (84.0%) | 31 (88.6%) | 0.95 [0.80–1.13] | 0.75 |
| Delivery of twin (% per total number of live birth deliveries) | 8 (16.0%) | 4 (11.4%) | 1.40 [0.46–4.26] | 0.75 |
Data are presented as numbers (%)
No.: number of cycles
NC: Not calculable
*: for exencephaly
a: The implantation rate was the ratio between the number of gestational sacs and the number of transferred embryos.
b: Clinical pregnancy was determined by the presence of an intrauterine gestational sac with a foetal heartbeat on ultrasound examination 4–5 weeks after the embryo transfer.
c: The delivery rate was the ratio between the number of deliveries and the number of embryo transfers.
Malformations.
| Detected during the neonatal period | 2 (5.1%) | 1 (3.2%) | |
| Detected after the neonatal period | 1 (2.8%) | 1 (3.3%) | |
| Detected during the neonatal period | 7 (18.0%) | 3 (9.7%) | |
| Detected after the neonatal period | 9 (25.0%) | 7 (23.3%) | |
| Cardiac | 2 (5.6%) | 1 (3.3%) | |
| Nervous system | 0 (0%) | 1 (3.3%) | |
| Limbs | 1 (2.8%) | 0 (0%) |
Available data are presented as numbers (%).
No.: number of singletons
aAll cardiac malformations were ventricular septal defect
bThe nervous system abnormality was a macrocrania with hydrocephalus but without intracranial hypertension and with a normal neurological development of the child.
c The limb abnormality was a bilateral syndactyly of the first knuckle of the 2nd and 3rd toes.
* Statistical analysis showed no difference between the groups, p>0.05
Singletons' medical history at 4 years old.
| 4.2 (0.2) | 4.1 (0.2) | ||
| 16.2 (2.3) | 16.0 (1.9) | ||
| 103.4 (4.3) | 104.2 (4.1) | ||
| 15.1 (1.3) | 14.8 (1.1) | ||
| 5 (13.9%) | 5 (16.7%) | ||
| 18 (50.0%) | 14 (46.7%) | ||
| 7 (19.4%) | 9 (30.0%) | ||
| 6 (16.7%) | 4 (13.3%) | ||
| 10 (27.8%) | 13 (43.3%) | ||
| 9 (25.0%) | 5 (16.7%) | ||
| 8 (22.2%) | 6 (20.0%) | ||
| Cardiac | 2 (5.6%) | 1 (3.3%) | |
| Pulmonary (asthma) | 4 (11.1%) | 4 (13.3%) | |
| Neurological | 1 (2.8%) | 1 (3.3%) | |
| ENT with secondary deafness | 1 (2.8%) | 1 (3.3%) | |
| Digestive | 1 (2.8%) | 0 (0%) | |
| Haematological | 1 (2.8%) | 0 (0%) | |
| Other diseases | 0 (0%) | 1 (3.3%) | |
| 8 (22.2%) | 5 (16.7%) | ||
| Circumcision | 1 (2.8%) | 3 (10.0%) | |
| Ventilating tube treatment | 4 (11.1%) | 3 (10.0%) | |
| Tonsillectomy | 1 (2.8%) | 1 (3.3%) | |
| Adenoid removal | 2 (5.6%) | 1 (3.3%) | |
| Other surgeries | 3 (8.3%) | 0 (0%) |
Available data are presented as numbers (%) or mean (SD)
BMI: Body Mass Index, ENT: Ear Nose and Throat, No.: number of singletons
* Statistical analysis showed no difference between the groups, p>0.05
Fig 1Development.
General developmental score (A) and proportion of children with developmental problems in at least one out of eight domains according to the CDI norms (B) in Global and SSM groups.